Agilent Technologies (A) revenue breakdown
By segment, Agilent CrossLab is the largest at 42% of fiscal 2025 revenue, growing 8% a year over 9 years.
By product, Non-Instrumentation and Other is the largest at 65% of fiscal 2025 revenue, growing 7% a year over 6 years.
Revenue by segment
Fiscal years, as Agilent Technologies reports them in its 10-K filings; fiscal 2025 total $6.9B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $1.4B | $1.5B | $1.7B | $1.8B | $1.2B | $1.4B | $1.5B | $2.7B | $2.7B | $2.9B | 42% |
| Life Sciences and Diagnostics Markets | — | — | — | — | — | — | — | $2.8B | $2.5B | $2.7B | 39% |
| Applied Markets | — | — | — | — | — | — | — | $1.4B | $1.3B | $1.3B | 19% |
| Life Sciences and Applied Markets | $2.0B | $2.1B | $2.3B | $2.3B | $3.1B | $3.7B | $3.6B | — | — | — | — |
| Diagnostics and Genomics | $790M | $860M | $943M | $1.0B | $1.0B | $1.3B | $1.8B | — | — | — | — |
Revenue by product
Fiscal years, as Agilent Technologies reports them in its 10-K filings; fiscal 2025 total $6.9B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Instrumentation and Other | — | — | — | $3.0B | $3.1B | $3.7B | $3.9B | $4.1B | $4.2B | $4.5B | 65% |
| Instrumentation | — | — | — | $2.1B | $2.2B | $2.7B | $2.9B | $2.7B | $2.4B | $2.4B | 35% |
| Products | — | — | $3.7B | — | — | — | — | — | — | — | — |
| Products | — | $3.4B | — | — | — | — | — | — | — | — | — |
| Instrumentation | $1.8B | — | — | — | — | — | — | — | — | — | — |
| Services and Other | — | — | $1.2B | — | — | — | — | — | — | — | — |
| Services and Other | — | $1.1B | — | — | — | — | — | — | — | — | — |
| Analytical Lab Services | $910M | — | — | — | — | — | — | — | — | — | — |
| Diagnostics and genomics solutions | $790M | — | — | — | — | — | — | — | — | — | — |
| Analytical lab consumables | $510M | — | — | — | — | — | — | — | — | — | — |
| Informatics and other | $202M | — | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Agilent Technologies reports them in its 10-K filings; fiscal 2025 total $6.9B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest Of World | $2.1B | $2.3B | $2.5B | $2.5B | $2.5B | $2.9B | $3.0B | $3.0B | $3.0B | $3.4B | 49% |
| UNITED STATES | $1.3B | $1.3B | $1.4B | $1.6B | $1.8B | $2.2B | $2.4B | $2.4B | $2.2B | $2.3B | 34% |
| CHINA Including Hong Kong | $839M | $900M | $1.0B | $1.0B | $1.1B | $1.3B | $1.5B | $1.4B | $1.2B | $1.2B | 18% |
Questions
Where does Agilent Technologies make its money?
In fiscal 2025, by segment: Agilent CrossLab $2.9B, Life Sciences and Diagnostics Markets $2.7B, Applied Markets $1.3B.
From Agilent Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.